The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon


Work +41 58 211 34 00
Fax +41 58 211 34 10

Dr Stefan Kohler

Work +41 58 211 34 19

Work Department

Intellectual Property Law, including Litigation and Arbitration Law; Healthcare Law, Pharmaceutical Law, Biotechnology Law, Law on Medical Devices; Regulatory Aspects of Life Sciences/New Technologies; Technology Transfer; Product Liability; Law against Unfair Competition; Advertising Law; Commercial Contracts; Data Protection; Administrativ Proceedings.


Partner; Co-head VISCHER Life Sciences Team; Head VISCHER IP Team


Lecturer at University of St Gallen (since 2007); Research Fellow(biosciences/biotechnology); Legal Research Assistant at the University of St Gallen; Clerkship and Associate with international corporate law firms in Zurich; Legal Counsel with a US-based (New Jersey) multinational pharmaceutical company; Consulting expert on the Swiss Federal legislation on biotechnology and pharmaceuticals; associate judge at Swiss Federal Patent Court.


German, English.


Zurich Bar Association; Swiss Bar Association; International Bar Association; Licensing Executive Society Switzerland (LES-CH) (Board Member); Forum for Genetic Research of the Swiss Academy of Sciences; International Association for the Protection of Intellectual Property (AIPPI); INGRES - Institute for industrial property.


Federal Institute of Technology (ETH) Zurich, Natural Sciences (dipl. sc. nat. ETH, 1994); University of St Gallen, Legal studies (lic. iur., 1997); University of St Gallen/ETH Zurich (Dr. iur., 2004).


Healthcare and life sciences

Within: Leading individuals

Stefan Kohler - VISCHER

Within: Healthcare and life sciences

VISCHER is renowned for its expertise in corporate, commercial, transactional, regulatory and patent-related healthcare and biotech matters. Matthias Staehelin assisted Medartis with its initial public offering on the SIX Swiss Exchange, while Stefan Kohler acted for Novo Nordisk Pharma in its appeal against a pricing decision made by the Swiss Federal Office of Public Health concerning the client's type-two diabetes product. Christian Wyss advised Lundbeck on its €905m acquisition of Prexton Therapeutics.

[back to top]

Intellectual property

Within: Intellectual property

The intellectual property department at VISCHER covers protective, strategic, transactional and contentious matters in relation to patents, copyright, designs and trade marks. Christian Wyss assisted Balderton Capital with the IP due diligence in preparation for its investment into Sophia Genetics' $30m financing round, while team lead Stefan Kohler advises Philipp Morris on the agreements required for the technological development of reduced-risk tobacco products. Rolf Der Maur, who combines intellectual property law with IT expertise, is another name to note.

[back to top]

Leading firms: German-speaking Switzerland

Within: Leading firms: German-speaking Switzerland

VISCHER has core strength in the healthcare, TMT and transport sectors and notable public law expertise, while also fielding strong capital markets, M&A, competition and litigation departments. Key partners include Stefan Kohler, Rolf Auf der Maur, Stefan Rechsteiner, Benedict Christ  and Christian Oetiker. Michael Waldner and Christian Wyss are other names to note.

[back to top]

Back to index

Legal Developments by:

  • Capital Contribution Principle: Meaning and Proceedings

    On January 1, 2011, the Swiss tax law capital contribution principle (CCP) enters into force - with far reaching consequences for companies, their owners, board members and tax advisors. A few days ago the Federal Tax Administration (FTA) published a Circular Letter on this change of law.

Legal Developments in Switzerland

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to